Drug Discovery

#Drug discovery #Drug screening #Lead optimisation

One stop for GPCR Drug Discovery Needs

This paid-for advertorial by Eurofins Discovery appeared in Volume 23 – Issue 3, Summer 2022. In the following article, Luke Oostdyk, Lakshmi Anantharaman and Nicole Servant from Eurofins Discovery discuss how G-Protein Coupled Receptor screening and profiling can advance drug discovery programs.  The sheer number of understudied and orphan receptors in… Read More

#Exclusive Content #Intelligence

Neuron
#Clinical research #Drug discovery #Motor neurone disease

Project granted £4.25m to advance research in motor neurone disease 

Six UK universities have collectively received £4.25 million as part of a collaborative project aimed at finding new treatments for motor neurone disease (MND).  The MND Collaborative Partnership was launched by LifeArc, MND Association, MND Scotland and My Name’5 Doddie Foundation, alongside government bodies Medical Research Council… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Immunotherapy #Synthetic biology

The summer issue of Drug Discovery World magazine is out now 

Featuring Specialty Spotlight: Immunotherapy, the magazine is available to download and read for free on the DDW App. Key features of the summer issue include: Why immunocompromised people are ‘forgotten’: Championing female leaders across drug discovery and development: Improving quality control for CAR T cell therapies, plus exclusive interviews and articles on… Read More

#News #Trending News

#Drug discovery #ELRIG #Events #Pharmacology

Event: New modalities in pharmacology and drug discovery

On 4 and 5 July 2022, The British Pharmacological Society and ELRIG UK will explore new pharmacological modalities of differing mechanisms, shapes and sizes and how these are being translated to create patient benefit at the Francis Crick Institute in London, UK. This is both a free and in-person event. Read More

#News

#Diversity #Drug discovery #Pharma #Women in STEM

App exclusive: Women in STEM: how to promote diversity in pharma

In this article exclusive to the Drug Discovery World app, Reece Armstrong speaks to Anca Ciobanu, Consultant and Strategic Theme Lead at the Pistoia Alliance about its Women in STEM pilot programme and some of the barriers women face for progressing through the life sciences sector. The article touches upon… Read More

#Exclusive Content

Monoclonal antibody
#Biologics #Biopharma #Drug development

New ebook: The researcher’s guide to Dynamic Light Scattering

This e-book by NanoTemper looks at the workflows researchers are using in the biologics space and the benefits dynamic light scattering (DLS) offers. You will find out: What biologics are and why they’re important How DLS gives you information about your samples and what that data means Tips and… Read More

#News

#Appointment #Drug discovery

Metrion Biosciences continues expansion with new hire  

Metrion Biosciences has appointed a Head of European Business Development to support the next phase of the company’s ion channel drug discovery services.   The company has appointed Dr Benedetta Montagnini as Head of European Business Development in a move which follows the recent creation of a Client… Read More

#News

#Assays #Drug discovery #Multiplexing #Screening

What you need to know about multiplexing in drug discovery

Download this guide from Abcam to learn more about: How multiplexing generates more insightful data The key principles, benefits and limitations of different multiplex assays How to select the most suitable multiplex assay for your screening program Click here to download… Read More

#News

#CRISPR #CRISPR screening #CRISPR-Cas9 #Drug discovery

Exclusive CRISPR-Cas9 screening event

Join DDW, supported by Horizon Discovery for this exclusive free event which will examine CRISPR-Cas9 screening and how it offers a powerful approach to advancing drug discovery and the understanding of genetic disease. The event will take place on 9 June 2022, 3PM BST. Register for free here. Joanna… Read More

#News

#Biology #Drug discovery #IBD

Galapagos advances IBD targets discovered using Scipher platform

Biotechnology company Galapagos will in-license drug targets for inflammatory bowel disease (IBD) which were discovered using a biology platform developed by Scipher Medicine. The move follows a deal Galapagos and Scipher Medicine made in 2020 to jointly validate a suite of novel IBD targets discovered by Scipher’s Spectra platform. Under… Read More

#News

#Drug development #Oncology #Podcast

Mini–library approach delivers an arsenal in drug development pipeline

This is the latest episode of the free DDW podcast, “Mini-library approach delivers an arsenal in drug development pipeline”. It covers a narrated article written for Volume 22, Issue 3 –Summer 2021 of DDW. In the article, Dr. Naganna Nimishetti, Chief of the Small Molecule Drug Discovery Division (SMDD) and… Read More

#News

#Drug development #Narrated podcasts #Oncology #Podcast

Mini-library approach delivers an arsenal in drug development pipeline

This is the latest episode of the free narrated DDW podcast, “Mini-library approach delivers an arsenal in drug development pipeline”. It covers a narrated article written for Volume 22, Issue 3 –Summer 2021 of DDW. In the article, Dr. Naganna Nimishetti, Chief of the Small Molecule Drug Discovery… Read More

#Podcasts

#AI / data analytics / healthtech / informatics #DEL #Drug discovery

AI in action: examples of AI across drug discovery

Drug discovery and development is a challenging multiparameter optimisation problem. Harnessing the power of artificial intelligence (AI) can help accurately predict the behaviour and properties of small molecules. In this on-demand webinar from X-Chem you will see: How AI and DNA-encoded library (DEL) screening are transforming early phase drug… Read More

#News

#CRISPR #CRISPR screening #CRISPR-Cas9 #Drug discovery

CRISPR-Cas9 screening: webinar

Join DDW, supported by Horizon Discovery for this exclusive free event which will examine CRISPR-Cas9 screening and how it offers a powerful approach to advancing drug discovery and the understanding of genetic disease. The event will take place on 9 June 2022, 3PM BST. Register for free here. Joanna… Read More

#News